| Full Name | Megan Evans |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 26 Years |
| Location | 150 Dresden Ave, Augusta, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376749911 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | CNP81336 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Maine General Medical Center | Augusta, ME | Hospital |
| Franklin Memorial Hospital | Farmington, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mainegeneral Medical Center | 1254245715 | 487 |
News Archive
LightLab Imaging, Inc., pioneer and leader in the development of Optical Coherence Tomography (OCT) for coronary artery applications, today reported that Trial Judge Margaret Hinkle has set March 22 for the commencement of the next phase of an ongoing trial to address damages LightLab Imaging is claiming against Volcano Corporation and its wholly owned subsidiary, Axsun Technologies, Inc.
The U.S. Food and Drug Administration have granted Roche a hearing in June to defend the cancer treatment Avastin. The hearing would examine the effectiveness of the drug in breast cancer.
Published clinical experience in over 2,000 patients who received autologous fat grafts showed no evidence of increased risk of development, metastasis or recurrence of breast cancer in contrast to laboratory data.
Two decades after its initiation, the University of Miami Linda Ray Intervention Program for substance-exposed babies and toddlers demonstrates long-term success.
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide human immunology registry for infectious disease research. The new registry was developed to help clinicians and researchers better understand the human immune response to emerging and re-emerging infectious diseases.
› Verified 2 days ago
| Entity Name | Mainegeneral Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669423380 PECOS PAC ID: 1254245715 Enrollment ID: O20031118000718 |
News Archive
LightLab Imaging, Inc., pioneer and leader in the development of Optical Coherence Tomography (OCT) for coronary artery applications, today reported that Trial Judge Margaret Hinkle has set March 22 for the commencement of the next phase of an ongoing trial to address damages LightLab Imaging is claiming against Volcano Corporation and its wholly owned subsidiary, Axsun Technologies, Inc.
The U.S. Food and Drug Administration have granted Roche a hearing in June to defend the cancer treatment Avastin. The hearing would examine the effectiveness of the drug in breast cancer.
Published clinical experience in over 2,000 patients who received autologous fat grafts showed no evidence of increased risk of development, metastasis or recurrence of breast cancer in contrast to laboratory data.
Two decades after its initiation, the University of Miami Linda Ray Intervention Program for substance-exposed babies and toddlers demonstrates long-term success.
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide human immunology registry for infectious disease research. The new registry was developed to help clinicians and researchers better understand the human immune response to emerging and re-emerging infectious diseases.
› Verified 2 days ago
| Entity Name | Mainegeneral Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063716710 PECOS PAC ID: 1254245715 Enrollment ID: O20110408000034 |
News Archive
LightLab Imaging, Inc., pioneer and leader in the development of Optical Coherence Tomography (OCT) for coronary artery applications, today reported that Trial Judge Margaret Hinkle has set March 22 for the commencement of the next phase of an ongoing trial to address damages LightLab Imaging is claiming against Volcano Corporation and its wholly owned subsidiary, Axsun Technologies, Inc.
The U.S. Food and Drug Administration have granted Roche a hearing in June to defend the cancer treatment Avastin. The hearing would examine the effectiveness of the drug in breast cancer.
Published clinical experience in over 2,000 patients who received autologous fat grafts showed no evidence of increased risk of development, metastasis or recurrence of breast cancer in contrast to laboratory data.
Two decades after its initiation, the University of Miami Linda Ray Intervention Program for substance-exposed babies and toddlers demonstrates long-term success.
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide human immunology registry for infectious disease research. The new registry was developed to help clinicians and researchers better understand the human immune response to emerging and re-emerging infectious diseases.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Megan Evans, NP 150 Dresden Ave, Augusta, ME 04330 Ph: (207) 621-3785 | Megan Evans, NP 150 Dresden Ave, Augusta, ME 04330 Ph: (207) 621-3785 |
News Archive
LightLab Imaging, Inc., pioneer and leader in the development of Optical Coherence Tomography (OCT) for coronary artery applications, today reported that Trial Judge Margaret Hinkle has set March 22 for the commencement of the next phase of an ongoing trial to address damages LightLab Imaging is claiming against Volcano Corporation and its wholly owned subsidiary, Axsun Technologies, Inc.
The U.S. Food and Drug Administration have granted Roche a hearing in June to defend the cancer treatment Avastin. The hearing would examine the effectiveness of the drug in breast cancer.
Published clinical experience in over 2,000 patients who received autologous fat grafts showed no evidence of increased risk of development, metastasis or recurrence of breast cancer in contrast to laboratory data.
Two decades after its initiation, the University of Miami Linda Ray Intervention Program for substance-exposed babies and toddlers demonstrates long-term success.
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide human immunology registry for infectious disease research. The new registry was developed to help clinicians and researchers better understand the human immune response to emerging and re-emerging infectious diseases.
› Verified 2 days ago
Nicole Letendre, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 35 Medical Center Pkwy, Augusta, ME 04330 Phone: 207-626-1360 Fax: 207-626-1359 | |
Pamela Slaughter, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 35 Medical Center Pkwy, Augusta, ME 04330 Phone: 207-248-0097 | |
Mr. Stephen G Brewer, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 250 Arsenal St, 11 Shs, Augusta, ME 04333 Phone: 207-624-4657 Fax: 207-287-6123 | |
Ms. Patricia Ann Keohan, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 330 Civic Center Dr, Augusta, ME 04330 Phone: 207-430-4321 Fax: 207-430-4320 | |
H Katrine Alcaide, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 43 Gabriel Dr, Augusta, ME 04330 Phone: 207-248-3932 | |
Jamie Sue Boutin, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 35 Medical Center Pkwy, Augusta, ME 04330 Phone: 207-626-1000 | |
Dr. Michelle Evangeline Breton, PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 841 Riverside Dr, Augusta, ME 04330 Phone: 844-294-5306 Fax: 844-294-5306 |